Abstract
UK Wound Care Management Investment Opportunities, Analysis and Forecasts to
2012
Summary
This report is an essential source for in-depth information and data relating
to UK wound care management market. It also offers detailed and comprehensive
coverage of market revenue, volume, distribution and company share
information; and latest news, financial deals and pipeline products
information of each of the key sub-segments of the wound care management in
UK
Scope
・ The report provides wound care management information broken down into
detailed categories and segments in United Kingdom.
・ Total revenues,
products sold, end users, and average pricing.
・ Market shares of all the
key competitors.
・ Key pipeline products that are set to shape the
market, broken down by sector.
・ Information on the top medical equipment
companies in the sector in the country covering business description,
strategic analysis, and financial information.
・ Healthcare structure,
regulatory environment, approval process, pricing trends and
reimbursement.
・ Product and brand updates, strategy changes, R&D
projects, corporate expansions and contractions and regulatory changes.
・
Key mergers and acquisitions, partnerships, private equity investments and
IPOs.
・ Customer, hospitals and physicians data.
Reasons to buy
・ Gain a strong understanding of the wound care management market in United
Kingdom.
・ Evaluate and compare the attractiveness of the market in the
country.
・ Identify growth segments and opportunities in each industry
sector within the country.
・ Evaluate the pipeline of key products that
will change the sector, and identify threats and opportunities before the
products are launched in the country.
・ Analyze the competitiveness of the
market in the country and identify hotspots.
・ Develop strategies based
on the latest product, brand, expansion and research and development news in
the country.
・ Do deals with an understanding of how competitors are
financed, and the mergers and partnerships that have shaped the market in the
country.
・ Identify and analyze the strengths and weaknesses of the
industry incumbents in the country.
Table of Contents
1 Table of Contents 2
1.1 List of Tables 8
1.2 List of Figures 11
2 Introduction 14
2.1 What Is This Report About? 14
2.2 Definitions
14
2.2.1 Wound Care Management 14
3 Healthcare Sector Review 16
3.1 Healthcare Expenditure 16
3.2 Healthcare Infrastructure 17
3.3
Healthcare Policy 19
4 Wound Care Management in United Kingdom 20
4.1
Wound Care Management Overall Revenues (2000-2012) 20
4.2 Wound Care
Management Overall Volume (2000-2012) 26
4.3 Wound Care Management Overall
Company Shares (2005-2006) 29
5 Wound Closure Devices in United Kingdom
30
5.1 Wound Closure Devices Overall Revenues (2000-2012) 30
5.1.1
Skin Closure Devices Overall Revenues (2000-2012) 33
5.1.2 Hemostats
Overall Revenues (2000-2012) 36
5.1.3 Tissue Sealants Overall Revenues
(2000-2012) 38
5.2 Wound Closure Devices Overall Volume (2000-2012) 40
5.2.1 Skin Closure Devices Overall Volume (2000-2012) 42
5.2.2 Tissue
Sealants Overall Volume (2000-2012) 44
5.2.3 Hemostats Overall Volume
(2000-2012) 46
5.3 Wound Closure Devices Average Price (2000-2012) 48
5.3.1 Hemostats Average Price (2000-2012) 48
5.3.2 Tissue Sealants Average
Price (2000-2012) 50
5.3.3 Skin Closure Devices Average Price (2000-2012)
52
5.4 Wound Closure Devices Distribution Share (2005-2006) 54
5.5
Wound Closure Devices Company Share (2005-2006) 55
6 Ostomy in United
Kingdom 56
6.1 Ostomy Overall Revenue (2000-2012) 56
6.2 Ostomy
Overall Volume (2000-2012) 58
6.3 Ostomy Average Price (2000-2012) 60
6.4 Ostomy Distribution Share (2005-2006) 62
6.5 Ostomy Company Share
(2005-2006) 63
7 Advance Wound Management in United Kingdom 64
7.1
Advanced Wound Management Overall Revenue (2000-2012) 64
7.2 Advanced
Wound Management Overall Volume (2000-2012) 66
7.3 Advanced Wound
Management Average Price (2000-2012) 68
7.4 Advanced Wound Management
Distribution Share (2005-2006) 70
7.5 Advanced Wound Management Company
Share (2005-2006) 71
8 Traditional Wound Management in United Kingdom
72
8.1 Traditional Wound Management Overall Revenue (2000-2012) 72
8.2
Traditional Wound Management Overall Volume (2000-2012) 74
8.3 Traditional
Wound Management Average Price (2000-2012) 76
8.4 Traditional Wound
Management Distribution Share (2005-2006) 78
8.5 Traditional Wound
Management Company Share (2005-2006) 79
9 Compression Therapy in United
Kingdom 80
9.1 Compression Therapy Overall Revenue (2000-2012) 80
9.2
Compression Therapy Overall Volume (2000-2012) 82
9.3 Compression Therapy
Average Price (2000-2012) 84
9.4 Compression Therapy Distribution Share
(2000-2012) 86
9.5 Compression Therapy Company Share (2005-2006) 87
10
HARTMANN GROUP Company Profile 88
10.1 Company Overview 88
10.2
Business Overview 88
10.2.1 Incontinence Management 88
10.2.2
Operating Theater Management 88
10.2.3 Other GROUP Activities 89
10.2.4 Wound Management 89
10.2.5 Products 89
10.2.6 History 90
10.3 Value Chain Analysis 92
10.3.1 Manufacturing 92
10.3.2 Product
Development 92
10.3.3 Sales and Marketing 93
10.4 SWOT Analysis 93
10.4.1 HARTMANN GROUP Strengths 93
10.4.2 HARTMANN GROUP Weaknesses 94
10.4.3 HARTMANN GROUP Opportunities 95
10.4.4 HARTMANN GROUP Threats
96
10.5 Financial and Operational Review 97
10.6 Locations And
Subsidiaries 98
11 Coloplast A/S Company Profile 100
11.1 Company
Overview 100
11.2 Business Overview 100
11.2.1 Medical Care 100
11.2.2 Major Products and Services 101
11.2.3 History 101
11.3 Value
Chain Analysis 103
11.3.1 Manufacturing 103
11.3.2 Product Development
103
11.3.3 Sales and Marketing 105
11.4 SWOT Analysis 105
11.4.1
Coloplast A/S Strengths 106
11.4.2 Coloplast A/S Weaknesses 106
11.4.3
Coloplast A/S Opportunities 107
11.4.4 Coloplast A/S Threats 107
11.5
Financial and Operational Review 109
11.5.1 Financial Statements 109
11.5.2 Financial Ratios 110
11.5.3 Share Holding Structure 111
11.6
Locations And Subsidiaries 112
12 ConvaTec Company Profile 114
12.1
Company Overview 114
12.2 Business Overview 114
12.2.1 Major Products
and Services 114
12.2.2 History 115
12.3 Locations And Subsidiaries
116
13 Baxter International, Inc. Company Profile 117
13.1 Company
Overview 117
13.2 Business Overview 117
13.2.1 BioScience 117
13.2.2 Medication Delivery 117
13.2.3 Renal 118
13.2.4 Products
118
13.2.5 History 119
13.3 Value Chain Analysis 121
13.3.1
Manufacturing 121
13.3.2 Product Development 122
13.3.3 Sales and
Marketing 123
13.4 SWOT Analysis 123
13.4.1 Baxter International Inc.
Strengths 123
13.4.2 Baxter International Inc. Weaknesses 124
13.4.3
Baxter International Inc. Opportunities 124
13.4.4 Baxter International
Inc. Threats 125
13.5 Financial and Operational Review 126
13.6
Locations And Subsidiaries 128
13.7 Baxter International Inc. Pipeline
Products 129
13.7.1 Next-Generation Home Hemodialysis Machine 129
14
Hollister Incorporated Company Profile 131
14.1 Company Overview 131
14.2 Business Overview 131
14.2.1 Major Products and Services 132
14.2.2 History 132
14.3 Locations And Subsidiaries 134
15 Regulation
System 136
15.1 Medical Equipment Approval Process 136
15.1.1
Classification of Medical Devices 136
15.1.2 Conformity Assessment Process
144
15.2 Medical Device approval fee 148
15.3 Post Market Surveillance
(PMS) 149
16 Pricing and Reimbursement 150
16.1 Market Pricing 150
16.2 Government Policies for Reimbursement 150
17 Distribution Structure
152
18 Financial Deals Landscape 153
18.1 Acquisition 153
18.1.1
Covidien Acquires Tissue Science Laboratories 153
18.2 Partnership 154
18.2.1 Kinetic Concepts Enters Into An Agreement With 3M Healthcare 154
18.2.2 3M Health Care Signs An Agreement With Greystone Pharmaceuticals
156
19 Recent Developments 158
19.1 Corporate Communications 158
19.1.1 Aug 28, 2008: Smith & Nephew Appoints President, North American
Business To Its Division 158
19.1.2 Jul 10, 2008: Smith & Nephew Names
Non-Executive Director 158
19.2 Legal and Regulatory 159
19.2.1 Aug
07, 2008: Smith & Nephew Delivered Notices Of Claims Against Plus Vendors
159
19.2.2 Jul 10, 2008: Angiotech Wins Before The UK House Of Lords
159
20 Appendix 160
20.1 Global Markets Direct Research Methodology
160
20.2 Coverage 161
20.3 Secondary Research 161
20.4 Primary
Research 162
20.5 Models 162
20.6 Forecasts 163
20.7 Expert Panels
163
20.8 Currency Conversion 164
20.9 Contact Us 165
20.10
Disclaimer 165
1.1 List of Tables
Table 1: Number of Doctor by
Specialty in UK, 2003 - 2007 18
Table 2: Wound Care Management, United
Kingdom, Overall Revenues ($ mn), 2000-2012 20
Table 3: Wound Care
Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
21
Table 4: Wound Care Management, United Kingdom, Overall Revenues ($
mn), Forecast, 2007-2012 22
Table 5: Wound Care Management, United
Kingdom, Category Revenues ($ mn), 2000-2012 23
Table 6: Wound Care
Management, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
24
Table 7: Wound Care Management, United Kingdom, Category Revenues ($
mn), Forecast, 2007-2012 25
Table 8: Wound Care Management, United
Kingdom, Category Volume (Units), 2000-2012 26
Table 9: Wound Care
Management, United Kingdom, Category Volume (Units), Historic, 2000-2007
27
Table 10: Wound Care Management, United Kingdom, Category Volume
(Units), Forecast, 2007-2012 28
Table 11: Wound Care Management in United
Kingdom, Overall, Company Share by Revenue ($ mn), 2005-2006 29
Table 12:
Wound Closure Devices, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 30
Table 13: Wound Closure Devices, United Kingdom, Overall
Revenues ($ mn), Forecast, 2007-2012 31
Table 14: Wound Closure Devices,
United Kingdom, Revenue by Segment ($ mn), Historic, 2000-2007 32
Table
15: Wound Closure Devices, United Kingdom, Revenue by Segment ($ mn),
Forecast, 2007-2012 33
Table 16: Skin Closure Devices, United Kingdom,
Overall Revenues ($ mn), Historic, 2000-2007 34
Table 17: Skin Closure
Devices, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 35
Table 18: Hemostats, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 36
Table 19: Hemostats, United Kingdom, Overall Revenues ($ mn),
Forecast, 2007-2012 37
Table 20: Tissue Sealants, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 38
Table 21: Tissue Sealants, United
Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 39
Table 22: Wound
Closure Devices, United Kingdom, Overall Volume (Units), Historic, 2000-2007
40
Table 23: Wound Closure Devices, United Kingdom, Overall Volume
(Units), Forecast, 2007-2012 41
Table 24: Skin Closure Devices, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 42
Table 25: Skin
Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
43
Table 26: Tissue Sealants, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 44
Table 27: Tissue Sealants, United Kingdom, Overall
Volume (Units), Forecast, 2007-2012 45
Table 28: Hemostats, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 46
Table 29:
Hemostats, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 47
Table 30: Hemostats, United Kingdom, Average Price ($), Historic, 2000-2007
48
Table 31: Hemostats, United Kingdom, Average Price ($), Forecast,
2007-2012 49
Table 32: Tissue Sealants, United Kingdom, Average Price ($),
Historic, 2000-2007 50
Table 33: Tissue Sealants, United Kingdom, Average
Price ($), Forecast, 2007-2012 51
Table 34: Skin Closure Devices, United
Kingdom, Average Price ($), Historic, 2000-2007 52
Table 35: Skin Closure
Devices, United Kingdom, Average Price ($), Forecast, 2007-2012 53
Table
36: Wound Closure Devices, United Kingdom, Distribution Share by Revenue ($
mn), 2005-2006 54
Table 37: Wound Closure Devices, United Kingdom, Company
Share by Revenue ($ mn), 2005-2006 55
Table 38: Ostomy, United Kingdom,
Overall Revenues ($ mn), Historic, 2000-2007 56
Table 39: Ostomy, United
Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 57
Table 40: Ostomy,
United Kingdom, Overall Volume (Units), Historic, 2000-2007 58
Table 41:
Ostomy, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 59
Table 42: Ostomy, United Kingdom, Average Price ($), Historic, 2000-2007
60
Table 43: Ostomy, United Kingdom, Average Price ($), Forecast,
2007-2012 61
Table 44: Ostomy, United Kingdom, Distribution Share by
Revenue ($ mn), 2005-2006 62
Table 45: Ostomy, United Kingdom, Company
Share by Revenue ($ mn), 2005-2006 63
Table 46: Advanced Wound Management,
United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 64
Table 47:
Advanced Wound Management, United Kingdom, Overall Revenues ($ mn), Forecast,
2007-2012 65
Table 48: Advanced Wound Management, United Kingdom, Overall
Volume (Units), Historic, 2000-2007 66
Table 49: Advanced Wound
Management, United Kingdom, Overall Volume (Units), Forecast, 2007-2012 67
Table 50: Advanced Wound Management, United Kingdom, Average Price ($),
Historic, 2000-2007 68
Table 51: Advanced Wound Management, United
Kingdom, Average Price ($), Forecast, 2007-2012 69
Table 52: Advanced
Wound Management, United Kingdom, Distribution Share by Revenue ($ mn),
2005-2006 70
Table 53: Advanced Wound Management, United Kingdom, Company
Share by Revenue ($ mn), 2005-2006 71
Table 54: Traditional Wound
Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
72
Table 55: Traditional Wound Management, United Kingdom, Overall
Revenues ($ mn), Forecast, 2007-2012 73
Table 56: Traditional Wound
Management, United Kingdom, Overall Volume (Units), Historic, 2000-2007 74
Table 57: Traditional Wound Management, United Kingdom, Overall Volume
(Units), Forecast, 2007-2012 75
Table 58: Traditional Wound Management,
United Kingdom, Average Price ($), Historic, 2000-2007 76
Table 59:
Traditional Wound Management, United Kingdom, Average Price ($), Forecast,
2007-2012 77
Table 60: Traditional Wound Management, United Kingdom,
Distribution Share by Revenue ($ mn), 2005-2006 78
Table 61: Traditional
Wound Management, United Kingdom, Company Share by Revenue ($ mn), 2005-2006
79
Table 62: Compression Therapy, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 80
Table 63: Compression Therapy, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 81
Table 64: Compression
Therapy, United Kingdom, Overall Volume (Units), Historic, 2000-2007 82
Table 65: Compression Therapy, United Kingdom, Overall Volume (Units),
Forecast, 2007-2012 83
Table 66: Compression Therapy, United Kingdom,
Average Price ($), Historic, 2000-2007 84
Table 67: Compression Therapy,
United Kingdom, Average Price ($), Forecast, 2007-2012 85
Table 68:
Compression Therapy, United Kingdom, Distribution Share by Revenue ($ mn),
2005-2006 86
Table 69: Compression Therapy, United Kingdom, Company Share
by Revenue ($ mn), 2005-2006 87
Table 70: HARTMANN GROUP, SWOT
Analysis, 2006 93
Table 71: HARTMANN GROUP, Financial Statements,
Euro Thousand, 2002-2006 97
Table 72: HARTMANN GROUP, Financial
Ratios, Euro Thousand, 2002-2006(Contd.) 98
Table 73: HARTMANN GROUP,
Subsidiaries 99
Table 74: Coloplast A/S, SWOT Analysis, 2007 105
Table 75: Coloplast A/S, Financial Statements, DKK Million, 2003-2007
109
Table 76: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007
110
Table 77: Coloplast A/S, Share Holding Structure 111
Table
78: Coloplast A/S, Other Locations 112
Table 79: Coloplast A/S,
Subsidiaries 112
Table 80: Coloplast A/S, Subsidiaries(Contd.)
113
Table 81: ConvaTec, Other Locations 116
Table 82: Baxter
International Inc., SWOT Analysis, 2006 123
Table 83: Baxter
International Inc., Financial Statements, USD Million, 2002-2006 126
Table
84: Baxter International Inc., Financial Ratios, USD Million, 2002-2006
(Contd.) 127
Table 85: Baxter International Inc., Other Locations
128
Table 86: Baxter International Inc., Subsidiaries 129
Table
87: Hollister Incorporated, Other Locations 134
Table 88:
Hollister Incorporated, Other Locations (Contd.) 135
Table 89:
Hollister Incorporated, Subsidiaries 135
Table 90: Medical Device Approval
Fee in UK, 2006 149
Table 91: Currency Conversion from USD to Local
Currency at 2007 Constant Rate 164
1.2 List of Figures
Figure 1:
Total Healthcare Expenditure in UK, 2000 - 2006 17
Figure 2: Wound Care
Management, United Kingdom, Overall Revenues ($ mn), 2000-2012 20
Figure 3
Wound Care Management, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 21
Figure 4: Wound Care Management, United Kingdom, Overall
Revenues ($ mn), Forecast, 2007-2012 22
Figure 5: Wound Care Management,
United Kingdom, Category Revenues ($ mn), 2000-2012 23
Figure 6: Wound
Care Management, United Kingdom, Category Revenues ($ mn), Historic, 2000-2007
24
Figure 7: Wound Care Management, United Kingdom, Category Revenues ($
mn), Forecast, 2007-2012 25
Figure 8: Wound Care Management, United
Kingdom, Category Volume (Units), 2000-2012 26
Figure 9: Wound Care
Management, United Kingdom, Category Volume (Units), Historic, 2000-2007
27
Figure 10: Wound Care Management, United Kingdom, Category Volume
(Units), Forecast, 2007-2012 28
Figure 11: Wound Care Management in United
Kingdom, Overall, Company Share (%), 2006 29
Figure 12: Wound Closure
Devices, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 30
Figure 13: Wound Closure Devices, United Kingdom, Overall Revenues ($ mn),
Forecast, 2007-2012 31
Figure 14: Wound Closure Devices, United Kingdom,
Revenue by Segment ($ mn), Historic, 2000-2007 32
Figure 15: Wound Closure
Devices, United Kingdom, Revenue by Segment ($ mn), Forecast, 2007-2012 33
Figure 16: Skin Closure Devices, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 34
Figure 17: Skin Closure Devices, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 35
Figure 18: Hemostats,
United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007 36
Figure 19:
Hemostats, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012 37
Figure 20: Tissue Sealants, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 38
Figure 21: Tissue Sealants, United Kingdom, Overall Revenues
($ mn), Forecast, 2007-2012 39
Figure 22: Wound Closure Devices, United
Kingdom, Overall Volume (Units), Historic, 2000-2007 40
Figure 23: Wound
Closure Devices, United Kingdom, Overall Volume (Units), Forecast, 2007-2012
41
Figure 24: Skin Closure Devices, United Kingdom, Overall Volume
(Units), Historic, 2000-2007 42
Figure 25: Skin Closure Devices, United
Kingdom, Overall Volume (Units), Forecast, 2007-2012 43
Figure 26: Tissue
Sealants, United Kingdom, Overall Volume (Units), Historic, 2000-2007 44
Figure 27: Tissue Sealants, United Kingdom, Overall Volume (Units), Forecast,
2007-2012 45
Figure 28: Hemostats, United Kingdom, Overall Volume (Units),
Historic, 2000-2007 46
Figure 29: Hemostats, United Kingdom, Overall
Volume (Units), Forecast, 2007-2012 47
Figure 30: Hemostats, United
Kingdom, Average Price ($), Historic, 2000-2007 48
Figure 31: Hemostats,
United Kingdom, Average Price ($), Forecast, 2007-2012 49
Figure 32:
Tissue Sealants, United Kingdom, Average Price ($), Historic, 2000-2007 50
Figure 33: Tissue Sealants, United Kingdom, Average Price ($), Forecast,
2007-2012 51
Figure 34: Skin Closure Devices, United Kingdom, Average
Price ($), Historic, 2000-2007 52
Figure 35: Skin Closure Devices, United
Kingdom, Average Price ($), Forecast, 2007-2012 53
Figure 36: Wound
Closure Devices, United Kingdom, Distribution Share (%), 2006 54
Figure
37: Wound Closure Devices, United Kingdom, Company Share (%), 2006 55
Figure 38: Ostomy, United Kingdom, Overall Revenues ($ mn), Historic,
2000-2007 56
Figure 39: Ostomy, United Kingdom, Overall Revenues ($ mn),
Forecast, 2007-2012 57
Figure 40: Ostomy, United Kingdom, Overall Volume
(Units), Historic, 2000-2007 58
Figure 41: Ostomy, United Kingdom, Overall
Volume (Units), Forecast, 2007-2012 59
Figure 42: Ostomy, United Kingdom,
Average Price ($), Historic, 2000-2007 60
Figure 43: Ostomy, United
Kingdom, Average Price ($), Forecast, 2007-2012 61
Figure 44: Ostomy,
United Kingdom, Company Share (%), 2006 63
Figure 45: Advanced Wound
Management, United Kingdom, Overall Revenues ($ mn), Historic, 2000-2007
64
Figure 46: Advanced Wound Management, United Kingdom, Overall Revenues
($ mn), Forecast, 2007-2012 65
Figure 47: Advanced Wound Management,
United Kingdom, Overall Volume (Units), Historic, 2000-2007 66
Figure 48:
Advanced Wound Management, United Kingdom, Overall Volume (Units), Forecast,
2007-2012 67
Figure 49: Advanced Wound Management, United Kingdom, Average
Price ($), Historic, 2000-2007 68
Figure 50: Advanced Wound Management,
United Kingdom, Average Price ($), Forecast, 2007-2012 69
Figure 51:
Advanced Wound Management, United Kingdom, Distribution Share (%), 2006 70
Figure 52: Advanced Wound Management, United Kingdom, Company Share (%), 2006
71
Figure 53: Traditional Wound Management, United Kingdom, Overall
Revenues ($ mn), Historic, 2000-2007 72
Figure 54: Traditional Wound
Management, United Kingdom, Overall Revenues ($ mn), Forecast, 2007-2012
73
Figure 55: Traditional Wound Management, United Kingdom, Overall Volume
(Units), Historic, 2000-2007 74
Figure 56: Traditional Wound Management,
United Kingdom, Overall Volume (Units), Forecast, 2007-2012 75
Figure 57:
Traditional Wound Management, United Kingdom, Average Price ($), Historic,
2000-2007 76
Figure 58: Traditional Wound Management, United Kingdom,
Average Price ($), Forecast, 2007-2012 77
Figure 59: Traditional Wound
Management, United Kingdom, Distribution Share (%), 2006 78
Figure 60:
Traditional Wound Management, United Kingdom, Company Share (%), 2006 79
Figure 61: Compression Therapy, United Kingdom, Overall Revenues ($ mn),
Historic, 2000-2007 80
Figure 62: Compression Therapy, United Kingdom,
Overall Revenues ($ mn), Forecast, 2007-2012 81
Figure 63: Compression
Therapy, United Kingdom, Overall Volume (Units), Historic, 2000-2007 82
Figure 64: Compression Therapy, United Kingdom, Overall Volume (Units),
Forecast, 2007-2012 83
Figure 65: Compression Therapy, United Kingdom,
Average Price ($), Historic, 2000-2007 84
Figure 66: Compression Therapy,
United Kingdom, Average Price ($), Forecast, 2007-2012 85
Figure 67:
Compression Therapy, United Kingdom, Distribution Share (%), 2006 86
Figure 68: Compression Therapy, United Kingdom, Company Share (%), 2006 87
Figure 69: HARTMANN GROUP, Value Chain Analysis 92
Figure 70:
Coloplast A/S, Value Chain Analysis 103
Figure 71: Baxter
International Inc., Value Chain Analysis 121
Figure 72: Flowchart for
Classification of Non-invasive Devices in UK, 2007 137
Figure 73:
Flowchart for Classification of Invasive Devices in UK, 2007 138
Figure
74: Flowchart for Classification of Invasive Devices in UK, 2007 139
Figure 75: Flowchart for Classification of Invasive Devices in UK, 2007
140
Figure 76: Flowchart for Classification of Invasive Devices in UK,
2007 141
Figure 77: Flowchart for Classification of Active Devices in UK,
2007 142
Figure 78: Flowchart for Classification of Active Devices in UK,
2007 143
Figure 79: Flowchart for Classification of Devices except
Non-invasive, Invasive and Active Devices in UK, 2007 144
Figure 80:
Conformity Assessment of Class-I Medical Devices in UK, 2007 145
Figure
81: Conformity Assessment of Class-IIa Medical Devices in UK, 2007 146
Figure 82: Conformity Assessment of Class-IIb Medical Devices in UK, 2007
147
Figure 83: Conformity Assessment of Class-III Medical Devices in UK,
2007 148
Figure 84: Global Markets Direct Methodology 160
